Press release
Psoriasis Treatment Market Size To Represent 7.3% CAGR till 2025 | COVID-19 Impact, Growth Insights, Future Trends and Share Estimation
Psoriasis Treatment Market
Psoriasis Market Overview
The Global Psoriasis Treatment Market is growing rapidly. The market growth attributes o the availability of several breakthrough therapeutics and drugs to treat symptoms of psoriasis. Over recent years, technological advancements have brought notable innovations in psoriasis treatments, offering phenomenal relief and benefitting results. These improvements increase the psoriasis market size, proving to be a boon to the patients by improving their quality of life.
According to Market Research Future (MRFR), the global psoriasis treatment market size is expected to reach USD 13.1 Billion by 2025, growing at 7.3% CAGR during the review period (2019-2025). Rising prevalence rate of psoriasis is one of the prime factors propelling market growth. Besides, the availability of breakthrough psoriasis drugs on the market fosters the growth of the market. Valuation of the market is anticipated to progress massively in the near future, witnessing the emergence of many new treatments.
Request Free Sample Copy at: https://www.marketresearchfuture.com/sample_request/2769
The increasing demand for effective psoriasis treatments pushes the market growth of the market to the ascended level. Conversely, the lack of awareness and unmet medical needs are the major factors expected to obstruct the market growth. Nevertheless, growing technology upgrades would support market growth throughout the assessment period. Furthermore, the increased funding for research and development from the public and private sectors would provide impetus to the market growth.
Psoriasis Treatment Market Segmentations
By Drug Class : Tumour Necrosis Factor Inhibitors (Adalimumab, Infliximab, Etanercept), K.in-Inhibitors (Ustekinumab, K.inumab, Ixekizumab, Brodalumab), Vitamin D Analogues (Calcitriol, Calcipotriol, Tacalcitol), and others.
By Treatment Type: Topicals (Over the Counter (OTC) Topicals, Topical Non-Steroids, Topical Steroids), Systemic (Retinoid, Cyclosporine, Methotrexate), Biologics (Tumour Necrosis Factor Alpha (TNF-a) Inhibitors, K.in 12 and 23 (IL-12/23) Inhibitors, K.in 17 (IL-17) Inhibitor, T Cell Inhibitor), and others.
Psoriasis Treatment Market Regional Outlook
North America dominates the global psoriasis treatments market. The largest market share attributes to the rising prevalence of psoriasis among children as well as adults. Besides, the strong presence of notable players and well-established treatment centers in the region impact the market growth positively. Moreover, high per capita healthcare expenditures and early adoption of new technology in the region substantiate the regional market growth. High cases of psoriasis in the US and Canada is expected to drive the market growth. The North American psoriasis treatments market is projected to retain its dominance over the global market throughout the forecast period.
Europe stands second in the global psoriasis treatment market. Positive amendments in the reimbursement policies drive the market. Furthermore, increasing expenses in research by healthcare bodies fuel the growth of the market in this region. Also, rising healthcare expenses allow the market to showcase a considerable amount of growth.
Additionally, the presence of a well-established healthcare system and key industry players, alongside technology upgrades in medical devices and therapeutics, drives the regional market growth. The European psoriasis treatments market is expected to create a substantial revenue pocket over the assessment period.
The Asia Pacific psoriasis treatments market is growing rapidly. Factors such as the increasing demand for spine surgeries and increasing government initiatives for healthcare reforms boost the regional market growth. Besides, a large patient pool and expansion of healthcare in the region drive the growth of the market. Furthermore, growing per capita healthcare expenditures and developing economies provide an impetus to the regional market. The APAC psoriasis treatments market is projected to have a steady growth rate during the forecast period.
Psoriasis Treatment Market Competitive Analysis
Highly competitive, the global psoriasis treatment market appears fragmented due to the presence of several well-established industry players. These players adopt strategic initiatives such as mergers & acquisitions, collaborations, expansion, and technology launch to gain a larger competitive advantage. Psoriasis pharmaceutical companies invest substantially in R&D and clinical trials to develop effective drugs and therapeutics.
Psoriasis pharmaceutical companies collaborate with a number of partners from academia to the biotech industry who contribute specialized knowledge and cutting-edge technologies to accelerate pharmaceutical innovations and gain a better understanding of the condition. These collaborations form one of the pillars of the company's innovation strategy. Through partnerships, companies can leverage scientific know-how and use it for innovative medicines. Partnerships can leverage innovative impulses that advance medicine and benefit patients and partners.
Major Players:
Players leading the psoriasis treatment market include UCB (Belgium), Novartis International AG (Switzerland), AstraZeneca (UK), Johnson & Johnson (US), Celgene Corporation (US), Pfizer Inc (US), AbbVie (US), Merck and Co. Inc (US), Eli Lilly and Company (US), and Amgen (US), among others.
Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/psoriasis-treatment-market-2769
Industry/Innovation/ Related News:
A team of researchers at John A. Paulson School of Engineering and Applied Sciences (SEAS) and Harvard's Wyss Institute for Biologically Inspired Engineering published their study, stating that siRNA-based treatment can reduce psoriasis symptoms significantly.
Scientists circumvented limitations by using an ionic liquid (IL) combination to deliver a small interfering RNA (siRNA)-based treatment successfully to the skin in a mouse model of psoriasis, significantly reducing levels of inflammatory cytokines and symptoms of psoriasis without systemic side effects.
Browse More Healthcare Related Research Report at:
Global Throat Lozenges Market Research Report- Forecast To 2027
https://www.marketresearchfuture.com/reports/throat-lozenges-market-1212
Global E-Health Services Market Research Report- Forecast To 2027
https://www.marketresearchfuture.com/reports/e-health-services-market-1252
Global Glaucoma Surgery Market Research Report- Forecast To 2027
https://www.marketresearchfuture.com/reports/glaucoma-surgery-market-1342
NOTE: Our team of researchers are studying Covid19 and its impact on various industry verticals and wherever required we will be considering covid19 footprints for a better analysis of markets and industries. Cordially get in touch for more details.
Contact:
Akash Anand
Market Research Future
+1 646 845 9312
Email: sales@marketresearchfuture.com
About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), & Consulting Services. MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Psoriasis Treatment Market Size To Represent 7.3% CAGR till 2025 | COVID-19 Impact, Growth Insights, Future Trends and Share Estimation here
News-ID: 2204620 • Views: …
More Releases from Market Research Future
Cerebral Palsy Industry Projected to Reach USD 4.036 billion by 2035 with Steady …
The global healthcare sector continues to place increasing emphasis on neurological disorders that require long-term management and multidisciplinary care. Among these, cerebral palsy remains one of the most common childhood motor disabilities, affecting movement, posture, and muscle coordination. As awareness grows and treatment options continue to advance, the cerebral palsy industry is witnessing steady expansion driven by improved diagnosis, therapeutic innovation, and rising investments in rehabilitation services.
According to Market Research…
Reclaimed Lumber Market revenue expected to rise from USD 53.47 Billion in 2024 …
Based on the market research report from Market Research Future, here is a detailed overview of the global reclaimed lumber market. This sector is thriving at the intersection of environmental sustainability and distinctive design.
What is Reclaimed Lumber?
Reclaimed lumber is wood sourced from old structures like barns, factories, warehouses, and wine barrels, which is then processed and remilled for new use. It offers a unique combination of environmental benefits-reducing deforestation and…
Cardiovascular Information Systems Industry Expected to Reach USD 1,330.86 milli …
The global healthcare sector is undergoing a rapid digital transformation, particularly in specialized areas such as cardiovascular care where data accuracy, workflow efficiency, and real-time monitoring are critical. Cardiovascular Information Systems (CVIS) have emerged as essential platforms that integrate imaging, patient records, diagnostic data, and clinical workflows to support comprehensive cardiac care management.
According to Market Research Future (MRFR), the Cardiovascular Information System Market was valued at USD 640.0 million in…
Low E-Glass Industry forecast highlights robust 6.5% CAGR growth through 2035
Low-emissivity (Low-E) glass has a microscopically thin, transparent coating that reflects infrared energy (heat) while allowing visible light to pass through. This principle helps keep buildings warm in the winter by reflecting interior heat back inside, and cool in the summer by blocking exterior heat, all while reducing harmful UV rays.
The Global Low-E Glass Market: An Overview
The global Low-E glass market is on a strong growth trajectory, driven by the…
More Releases for Psoriasis
Prevalence Of Psoriasis Driving Market Growth: A Key Catalyst Accelerating Psori …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
Over the recent years, there has been a robust growth in the size of the psoriasis market. It is estimated to rise from $26.45 billion in 2024 to $28.93 billion in 2025, with a compound annual…
Psoriasis Vulgaris Market
Introduction
Psoriasis vulgaris, also known as plaque psoriasis, is the most common form of psoriasis, accounting for nearly 80-90% of all cases. It is a chronic autoimmune condition marked by red, scaly plaques that can cause significant physical discomfort and emotional distress. Affecting millions worldwide, psoriasis vulgaris is increasingly recognized as both a dermatological and systemic disease due to its association with arthritis, cardiovascular disease, and metabolic syndrome.
The global psoriasis vulgaris…
Major Growth Driver Identified in 2025 Psoriasis Market: Prevalence Of Psoriasis …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
Psoriasis Market Size Valuation Forecast: What Will the Market Be Worth by 2025?
In recent times, the size of the psoriasis market has experienced a significant increase. It is projected to escalate from $26.56 billion in 2024 to $29.5 billion in 2025, reflecting a compound annual growth rate (CAGR)…
Prevalence Of Psoriasis Driving Market Growth: Key Factor Driving The Growth In …
The Psoriasis Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Psoriasis Market Size During the Forecast Period?
The psoriasis market has seen rapid growth in recent years. It will increase from $26.56 billion in 2024 to $29.5 billion in 2025, at a…
Plaque Psoriasis to Hold 85% Share of Psoriasis Drugs Market through 2031
Psoriasis is a chronic inflammatory skin disease that occurs due to genetic disposition and environmental factors. Psoriasis is a systemic disease associated with psychological, metabolic, arthritic, and cardiovascular comorbidities. On an average, psoriasis affects around 2 - 3% of the population globally.
Plaque psoriasis, being the number one and most common indication, held nearly 85% share of the US$ 11.37 Bn psoriasis drugs market in 2021, with the market estimated to…
Global Psoriasis Market with Focus on Plaque Psoriasis: Outlook to 2020
Psoriasis is a chronic inflammatory skin disease primarily causing scaling and inflammation of skin, characterized by sharply demarcated, scaly, red skin lesions most often on the elbows, knees, scalps, hands and feet. It occurs when the body’s immune system sends out faulty signals that speed up the growth cycle of skin cells. Psoriasis has been majorly classified into Plaque psoriasis, Guttate psoriasis, Inverse psoriasis, Pustular psoriasis and Erytherodermic psoriasis. It…
